However, for other diseases, such as cardiovascular disease, diabetes, or certain cancers, the underlying genetics is much more complex, which magnifies the difficulty to translate SNP technologies into the clinic.Another challenge is making sense of the SNP data. ???Demonstrating clinical utility of SNP genotyping is going to be important,??? says Dickinson, ???At this time, it is not technology-